ClinicalTrials.gov
public full text
Public Domain
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
The study will assess the safety and efficacy of Everolimus (RAD001) alone or in combination with Lucentis in patients with neo-vascular age related macular degeneration (AMD)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation#894615
- Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure#1125783
- Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)#918947
- Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers#1010091
- Norspan Efficacy and Safety Among Elderly Subjects#843949
Record · ID 1184175
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive